These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26708211)

  • 21. The when, why, and how of using glycopyrronium to diminish drooling in children with neurodevelopmental disabilities: Implications for clinical practice.
    Orriëns LB; van der Burg JJW; van den Hoogen FJA; Willemsen MAAP; van Hulst K; Erasmus CE
    Eur J Paediatr Neurol; 2024 Jul; 51():24-31. PubMed ID: 38776696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of salivary gland botulinum Toxin-A on drooling and respiratory morbidity in children with neurological dysfunction.
    Gubbay A; Marie Blackmore A
    Int J Pediatr Otorhinolaryngol; 2019 Sep; 124():124-128. PubMed ID: 31185343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual atropine for the treatment of severe and hyoscine-resistant clozapine-induced sialorrhea.
    Mustafa FA; Khan A; Burke J; Cox M; Sherif S
    Afr J Psychiatry (Johannesbg); 2013 Jul; 16(4):242. PubMed ID: 24051562
    [No Abstract]   [Full Text] [Related]  

  • 25. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ; Glasson C; O'Flaherty SJ
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
    Jongerius PH; Rotteveel JJ; van den Hoogen F; Joosten F; van Hulst K; Gabreëls FJ
    Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling.
    van der Burg JJ; Jongerius PH; van Limbeek J; van Hulst K; Rotteveel JJ
    Eur J Pediatr; 2006 Jan; 165(1):37-41. PubMed ID: 16172877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of drooling in disabled patients with scopolamine patches.
    Mato A; Limeres J; Tomás I; Muñoz M; Abuín C; Feijoo JF; Diz P
    Br J Clin Pharmacol; 2010 Jun; 69(6):684-8. PubMed ID: 20565460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N; Penn C
    Int J Lang Commun Disord; 2011; 46(5):550-63. PubMed ID: 21899672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the addition of sublingual gland excision to submandibular duct relocation give better overall results in drooling control?
    Glynn F; O'Dwyer TP
    Clin Otolaryngol; 2007 Apr; 32(2):103-7. PubMed ID: 17403225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics of atropine oral gel formulation in healthy volunteers.
    Parrot M; Yathavan B; Averin O; Hoggard L; Rower JE; Voight M; Greene D; Tarrell A; Whelan A; Ghandehari H; Murphy N; Yellepeddi V
    Clin Transl Sci; 2024 Mar; 17(3):e13753. PubMed ID: 38465519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What to do in neuroleptic-induced sialorrhea].
    Fischer RB
    Psychiatr Prax; 2001 Jul; 28(5):249-50. PubMed ID: 11517914
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticholinergic medications for reducing drooling in children with developmental disability.
    Reid SM; Westbury C; Guzys AT; Reddihough DS
    Dev Med Child Neurol; 2020 Mar; 62(3):346-353. PubMed ID: 31495925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary study of glycopyrrolate in the management of drooling.
    Stern LM
    J Paediatr Child Health; 1997 Feb; 33(1):52-4. PubMed ID: 9069045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Submandibular gland botulinum neurotoxin A injection for predicting the outcome of submandibular duct relocation in drooling: a retrospective cohort study.
    Kok SE; van Valenberg HFJP; van Hulst K; Jongerius P; Erasmus CE; van den Hoogen FJA
    Dev Med Child Neurol; 2019 Nov; 61(11):1323-1328. PubMed ID: 30854648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonsurgical treatment of drooling in a patient with closed head injury and severe dysarthria.
    Dworkin JP; Nadal JC
    Dysphagia; 1991; 6(1):40-9. PubMed ID: 1884637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atropine eyedrops for death rattle in a terminal cancer patient.
    Shinjo T; Okada M
    J Palliat Med; 2013 Feb; 16(2):212-3. PubMed ID: 22747099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycopyrrolate treatment of chronic drooling.
    Blasco PA; Stansbury JC
    Arch Pediatr Adolesc Med; 1996 Sep; 150(9):932-5. PubMed ID: 8790123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B; Aslami B; Backes H
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential problems surrounding the use of sublingually administered ophthalmic atropine for sialorrhea.
    Leung JG; Schak KM
    Schizophr Res; 2017 Jul; 185():202-203. PubMed ID: 28043733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.